Dyck | NoSHO

: 1993 AJP Moban; Molindone HCl, Gate Pharmaceuticals, A pair of hands holding a blue and gold egg-shaped object, that is standing on to of a black and gold platform. Also a medicine bottle, medicine dropper, and multiple different coloured and sized pills/tablets. Half page ad; found next to the table of contents.

: 1993 AJP Orap; Pimozide, Gate Pharmaceuticals, Drawing of 4 white tablets/pills with "ORAP 2" written on them. Green background. Half page ad. Beside this ad is a small ad for some sort of computerized system. Another small ad is present for a study looking for childhood-onset schizophrenia participants.

: 1993 AJP Prozac; To help restore daily functioning Prozac fluoxetine hydrochloride The first highly selective, highly potent blocker of serotonin uptake. Effectively relieves depression. Over 4 million patients treated in the US. The #1 prescribed antidepressant by US psychiatrists. Convenient dosage: 20 mg once a day., Fluoxetine hydrochloride, Dista Products Company, 3 sketches of the same female's face; first 2 are white in colour, and have a negative then neutral expression. Final sketch is in colour with a positive expression. Shows the progression from negative to positive, also from no colour to colour. 2 page ad. Fine print included. The "O" in "Prozac" looks to be a sunset with white lines across it.

: 1993 AJP Valium; Settle the issue state by state…Brand necessary N.D.P.S. May not substitute. Medically necessary. No substitution. Do not substitute. Dispense as written. Valium brand of diazepam/Roche. The final choice should really be yours., Diazepam, Roche Products, Black and white background; the white is a piece of paper where the full text is written on. A pen is laying beside the paper. Also, 3 different coloured tablets/pills. "Brand necessary" is used to make sure the name brand is prescribed.

: 1993 AJP Xanax; For anxiety with associated depressive symptoms. Tablets Xanax alprazolam. As with all benzodiazepines, drowsiness is the most common side effect., Alprazolam, The Upjohn Company; Solvay Pharmaceuticals, Blue and red painted splattered in all directions; looks like somebody took a paint brush and swung the brush close to the page causing the "splattering" effect. Also three tablets are pictured. 2 page ad. Fine print included.

: 1993 AJP Zoloft; Once-a-day Zoloft (sertraline HCl). Gets depressed patients back into the mainstream. Zoloft: Move Forward with Confidence. A selective serotonin reuptake inhibitor - chemically distinct from all other antidepressants. Effective in the treatment of depression - improves mood and enhances patients' ability to function. Once-daily dosing - can be taken in the morning or evening, with or without food. Available in 50-mg and 100-mg scored tablets for flexible dosing. The most common side effects include nausea, diarrhea or loose stools, tremor, insomnia, somnolence, and dry mouth. Once-a-day Zoloft (sertraline HCl) From depresion…into the mainstream., Sertraline HCl, Pfizer Roerig Pratt Pharmaceuticals, Image of a female patient doing daily activities with a smile on her face; some activities include golf, work, being with husband, etc. Background of this is multi-coloured. "Zoloft" has a yellow star beside the name. 2 page ad. Fine print included.

: 1993 ANZJP Aropax 20; Now there's an antidepressant that can reach more of your targets. Aropax 20 is a new Selective Serotonin Reuptake Inhibitor that is more potent and selective than other available antidepressants…so it can help you and your patient reach more of your therapeutic targets. Aropax 20 relieves depression and can improve associated anxiety symptoms and sleep disturbance, with a benign side effect profile. The starting dose of 20mg once-daily is also the optimal dose for most patients. Aropax 20 aims for success., Paroxetine, SmithKline Beecham Pty Ltd., A smiling woman standing on her porch in her robe holding a mug of coffee.

: 1993 ANZJP Aurorix; The power to lift depression. The first R.I.M.A. antidepressant: 1. Rapid relief from depression. 2. Extremely well tolerated. 3. Low risk in overdose. 4. No weight gain. 5. Simple dosage regime., Moclodemide, Roche Products Limited, Image of window shade with dark, stormy clouds on it lifting up to reveal clear skies. Also, an image of a green traffic light.

: 1993 ANZJP Aurorix; Aurorix. New horizons in the treatment of depression. The first R.I.M.A. moclobemide Aurorix., Moclobemide, Roche Products Limited, A green traffic light.

: 1993 ANZJP Prothiaden; This picture on the outside back cover, from the Cunnigham Dax Collection of psychiatric art, is sponsored by: Prothiaden. Still setting the standard in antidepressant therapy. Outside back cover: From the Cunnigham Dax Collection of Psychiatric Art. Mania. Elation, explosion of colour, clown-like jack-in-the-box. Flight of ideas and multiple symbols, uncommon because in mania a picture is rarely so complete. E.C.D., Dothiepin Hydrochloride B.P., The Boots Company Pty Limited, "This picture on the outside back cover" refers to ANZJP148.

: 1993 ANZJP Prothiaden; This picture, from the Cunningham Dax Collection of psychiatric art, is sponsored by: Prothiaden., Dothiepin Hydrochloride B.P., The Boots Company Pty Limited, Image of a painting of a narrow path on a mountain with a farm in the background.

: 1993 ANZJP Prothiaden; This picture, from the Cunningham Dax Collection of psychiatric art, is sponsored by PROTHIADEN. The picture on the outside back cover, from the Cunningham Dax Collection of psychiatric art is sponsered by: Prothiaden. Still setting the standard in antidepressant therapy. Outside back cover: From the Cunningham Dax Collection of Psychiatric Art. Depression. Sorrow, shame and self-pity. Guilt feeling, fear of punishment by hanging. Suicidal gesture bleeding from a cut wrist and crying tears of blood. E.C.D., dothiepin Hydrochlroide B.P., Boots Pharmaceuticlas PTY LIMITED, A piece of psychiatric art from the Cunningham Dax collection, two-page ad.

: 1993 ANZJP Prothiaden; The Cunningham Dax Collection of psychiatric art, sponsored by: Prothiaden. Still setting the standard in antidepressant therapy. Outside back cover: from the Cunnigham Dax Collection of Psychiatric Art. Schizophrena. Paintings by patients with schizophrenia often show fusion of thoughts, body image disturbance and composite figures. Facial features, for example, may disappear leaving only an encircled eye. In this illustration an eye and hair are shown in a rudimentary body. E.C.D., Dothiepin Hydrochloride B.P., The Boots Company Pty Limited, "Outside back cover" refers to ANZJP145.

: 1993 ANZJP Prothiaden; This picture, from the Cunnigham Dax Collection of psychiatric art, is sponsored by: Prothiaden., Dothiepin Hydrochloride B.P., The Boots Company Pty Limited, Image of an abstract painting with swirls and music notes.

: 1993 ANZJP Prothiaden; In depression with anxiety and sleep problems…Prothiaden brings relief. Relieves depression and anxiety…restores normal sleep., Dothiepin Hydrochloride B.P., The Boots Company Pty Limited, A face imprinted in pin art.

: 1993 ANZJP Prothiaden; This picture on the outside back cover, from the Cunnigham Dax collection of psychiatric art, is sponsored by: Prothiaden. Still setting the standard in antidepressant therapy. Outside back cover: From the Cunnigham Dax Collection of Psychiatric Art. Anxiety. A bare, dangerous road leading nowhere. A flight from habitation with catostrophe at the end. A powerless attempt to escape through a steep desolate landscape. E.C.D., Dothiepin Hydrochloride B.P., The Boots Company Pty Limited, "This picture on the outside back cover" refers to ANZJP155.

: 1993 ANZJP Prothiaden; The Cunningham Dax Collection of psychiatric art, sponsored by: Prothiaden., Dothiepin Hydrochloride B.P., The Boots Company Pty Limited, Image of a painting, two-page ad.

: 1993 ANZJP Roxiam; A major advance in antipsychotic therapy. Roxiam (remoxipride) is a new antipsychotic which is the result of intensive CNS research by Astra Pharmaceuticals. Roxiam, a selective dopamine-D2 receptor antagonist, was developed to provide an optimal therapeutic effect together with a favourable side-effect profile. Roxiam has been shown to be an effective antipsychotic with efficacy equivalent to that of haloperidol in the treatment of schizophrenia. Due to the selective activity of remoxipride on the D2 receptor, clinical trials have clearly established Roxiam as an agent which has substantially less extrapyramidal involvement, a lower incidence of central nervous system effects and a minimal sedative potential compared to classical antipsychotics. Roxiam, Widening the margin between efficacy and side effects. Roxiam. The D2 specific antipsychotic., Remoxipride, Astra Pharmaceuticals Pty. Ltd., A mannequin's profile showing the dopamine receptors in the brain. The D2 receptors are lit up while the D1 receptors are not. two-page ad

: 1993 ANZJP Serepax; Short term therapy for anxiety serepax helps calm anxious patients., Oxazepam, Wyeth Pharmaceuticals Pty Limited, A man and a child on a forest path in the autumn.

: 1993 ANZJP Tolvon; Authority Lifted. Tolvon now pbs (sp) 1+5 repeats. Severe depression, Mianserin Hydrochloride, Organon Pty Limited.